BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25374241)

  • 21. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women.
    Park JH; Kim YS; Ahn SD; Choi EK; Shin SS; Kim YT; Kim YM; Kim JH; Yi SY; Nam JH
    Tumori; 2010; 96(6):959-65. PubMed ID: 21388059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency.
    Rosenblatt E; Abdel-Wahab M; El-Gantiry M; Elattar I; Bourque JM; Afiane M; Benjaafar N; Abubaker S; Chansilpa Y; Vikram B; Levendag P
    Radiat Oncol; 2014 Mar; 9():67. PubMed ID: 24581393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
    Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Monnier L; Touboul E; Daraï E; Lefranc JP; Lauratet B; Ballester M; Huguet F
    Bull Cancer; 2016 Feb; 103(2):164-72. PubMed ID: 26822905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
    Maruyama Y; Bowen MG; Van Nagell JR; Gallion HH; DePriest P; Wierzbicki J
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):529-34. PubMed ID: 8005811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
    Liang JA; Chen SW; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
    Int J Gynecol Cancer; 2014 Jun; 24(5):901-7. PubMed ID: 23975081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daily low-dose Cisplatin-based concurrent chemoradiotherapy for the treatment of cervical cancer in patients 70 years or older.
    Hanawa S; Mitsuhashi A; Usui H; Yamamoto N; Watanabe-Nemoto M; Nishikimi K; Uehara T; Tate S; Uno T; Shozu M
    Int J Gynecol Cancer; 2015 Jun; 25(5):891-6. PubMed ID: 25811592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
    Schefter TE; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1179-84. PubMed ID: 22342094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.
    Manders DB; Morón A; McIntire D; Miller DS; Richardson DL; Kehoe SM; Albuquerque KV; Lea JS
    Am J Clin Oncol; 2018 May; 41(5):447-451. PubMed ID: 27258678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer.
    Cihoric N; Tsikkinis A; Tapia C; Aebersold DM; Zlobec I; Lössl K
    Radiat Oncol; 2015 Nov; 10():240. PubMed ID: 26597282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-fraction HDR brachytherapy in locally advanced cervical cancer: A monocentric experience.
    Ogorodniitchouk O; Aunier J; Bousarsar A; Lahmamssi C; Sotton S; Ouaz H; Moreno-Acosta P; Moslemi D; Molekzadehmoghani M; Langrand-Escure J; Magne N; Vallard A
    Cancer Radiother; 2021 Jul; 25(5):463-468. PubMed ID: 34023215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
    Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
    Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?
    Yuce Sari S; Guler OC; Gultekin M; Onal HC; Yildiz F
    Oncol Res Treat; 2017; 40(9):523-527. PubMed ID: 28848218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Radiation Field Failure After Definitive Chemoradiation in Patients With Locally Advanced Cervical Cancer.
    Bae HS; Kim YJ; Lim MC; Seo SS; Park SY; Kang S; Kim SH; Kim JY
    Int J Gynecol Cancer; 2016 May; 26(4):737-42. PubMed ID: 26937749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A; Sia S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.